Acadia Net Receivables vs Common Stock Analysis
ACHC Stock | USD 66.27 0.91 1.39% |
Acadia Healthcare financial indicator trend analysis is way more than just evaluating Acadia Healthcare prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Acadia Healthcare is a good investment. Please check the relationship between Acadia Healthcare Net Receivables and its Common Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acadia Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade Acadia Stock refer to our How to Trade Acadia Stock guide.
Net Receivables vs Common Stock
Net Receivables vs Common Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Acadia Healthcare Net Receivables account and Common Stock. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Acadia Healthcare's Net Receivables and Common Stock is 0.94. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Common Stock in the same time period over historical financial statements of Acadia Healthcare, assuming nothing else is changed. The correlation between historical values of Acadia Healthcare's Net Receivables and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Acadia Healthcare are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Net Receivables i.e., Acadia Healthcare's Net Receivables and Common Stock go up and down completely randomly.
Correlation Coefficient | 0.94 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Net Receivables
Common Stock
Most indicators from Acadia Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Acadia Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acadia Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade Acadia Stock refer to our How to Trade Acadia Stock guide.At present, Acadia Healthcare's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.64, whereas Discontinued Operations is forecasted to decline to (11.9 M).
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 77.0M | 69.8M | 82.1M | 106.0M | Depreciation And Amortization | 106.7M | 117.8M | 132.3M | 92.7M |
Acadia Healthcare fundamental ratios Correlations
Click cells to compare fundamentals
Acadia Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Acadia Healthcare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 87.8M | 88.6M | 90.8M | 91.6M | 90.9M | 68.4M | |
Total Assets | 6.9B | 6.5B | 4.8B | 5.0B | 5.4B | 4.4B | |
Other Current Liab | 225.2M | 1.0B | 234.0M | 229.2M | 671.0M | 704.6M | |
Total Current Liabilities | 463.6M | 1.3B | 404.9M | 388.3M | 885.8M | 930.1M | |
Total Stockholder Equity | 2.5B | 1.9B | 2.5B | 2.8B | 2.8B | 1.8B | |
Other Liab | 225.7M | 183.4M | 184.9M | 206.8M | 237.8M | 144.7M | |
Accounts Payable | 127.0M | 87.8M | 98.6M | 104.7M | 156.1M | 84.8M | |
Cash | 124.2M | 378.7M | 133.8M | 97.6M | 100.1M | 97.3M | |
Good Will | 2.4B | 2.1B | 2.2B | 2.2B | 2.2B | 1.8B | |
Inventory | 4.8M | 4.9M | 4.8M | 5.1M | 5.3M | 5.6M | |
Other Current Assets | 78.2M | 61.3M | 79.9M | 86.0M | 61.1M | 65.1M | |
Total Liab | 4.4B | 4.6B | 2.2B | 2.1B | 2.5B | 2.6B | |
Intangible Assets | 90.4M | 68.5M | 70.1M | 76.0M | 73.3M | 60.8M | |
Common Stock | 877K | 880K | 890K | 899K | 913K | 777.4K | |
Property Plant Equipment | 3.2B | 1.6B | 1.9B | 2.1B | 2.4B | 1.8B | |
Short Long Term Debt Total | 3.7B | 3.2B | 1.6B | 1.5B | 1.5B | 2.2B | |
Net Tangible Assets | (956K) | (219.0M) | 247.4M | 513.9M | 591.0M | 620.5M | |
Property Plant And Equipment Net | 3.7B | 1.7B | 1.9B | 2.1B | 2.4B | 2.0B | |
Net Debt | 3.6B | 2.8B | 1.5B | 1.4B | 1.4B | 2.1B | |
Retained Earnings | 361.7M | (310.4M) | (119.8M) | 153.4M | 131.7M | 117.6M | |
Non Current Assets Total | 6.3B | 4.0B | 4.3B | 4.5B | 4.8B | 4.2B | |
Non Currrent Assets Other | 62.7M | 58.7M | 67.9M | 65.1M | 43.9M | 50.9M | |
Other Assets | 71.6M | 179.3M | 98.0M | 95.6M | 110.0M | 91.0M | |
Long Term Debt | 3.1B | 3.0B | 1.5B | 1.4B | 1.3B | 2.1B | |
Cash And Short Term Investments | 124.2M | 378.7M | 133.8M | 97.6M | 100.1M | 104.0M | |
Net Receivables | 339.8M | 273.6M | 281.3M | 322.4M | 429.5M | 258.5M | |
Common Stock Total Equity | 874K | 877K | 880K | 890K | 1.0M | 787.9K | |
Retained Earnings Total Equity | 252.8M | 361.7M | (310.4M) | (119.8M) | (107.8M) | (102.4M) | |
Long Term Debt Total | 3.2B | 3.1B | 3.0B | 1.5B | 1.7B | 2.3B | |
Liabilities And Stockholders Equity | 6.9B | 6.5B | 4.8B | 5.0B | 5.4B | 4.8B | |
Non Current Liabilities Total | 3.9B | 3.3B | 1.8B | 1.7B | 1.6B | 2.3B | |
Capital Surpluse | 2.5B | 2.6B | 2.6B | 2.6B | 3.0B | 2.0B | |
Other Stockholder Equity | 2.6B | 2.6B | 2.6B | 2.7B | 2.6B | 2.0B | |
Deferred Long Term Liab | 80.4M | 140.8M | 50.0M | 74.4M | 85.5M | 60.0M | |
Property Plant And Equipment Gross | 3.2B | 1.7B | 1.9B | 2.1B | 3.2B | 2.1B | |
Total Current Assets | 542.2M | 2.5B | 495.0M | 506.1M | 596M | 590.6M | |
Non Current Liabilities Other | 630.8M | 217.4M | 227.3M | 125.0M | 140.1M | 180.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Acadia Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Acadia Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Acadia Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Acadia Healthcare Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acadia Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade Acadia Stock refer to our How to Trade Acadia Stock guide.Note that the Acadia Healthcare information on this page should be used as a complementary analysis to other Acadia Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Acadia Stock analysis
When running Acadia Healthcare's price analysis, check to measure Acadia Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acadia Healthcare is operating at the current time. Most of Acadia Healthcare's value examination focuses on studying past and present price action to predict the probability of Acadia Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acadia Healthcare's price. Additionally, you may evaluate how the addition of Acadia Healthcare to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Acadia Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acadia Healthcare. If investors know Acadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acadia Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.153 | Earnings Share (0.13) | Revenue Per Share 32.79 | Quarterly Revenue Growth 0.091 | Return On Assets 0.062 |
The market value of Acadia Healthcare is measured differently than its book value, which is the value of Acadia that is recorded on the company's balance sheet. Investors also form their own opinion of Acadia Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Acadia Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acadia Healthcare's market value can be influenced by many factors that don't directly affect Acadia Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acadia Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Acadia Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acadia Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.